Results
Fischer Medical Ventures FY26 Loss Rs.104.2 Cr Standalone
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting a standalone net loss of ₹104.23 crore for the year.
Recommended a final dividend of
